Trials / Completed
CompletedNCT03645863
Effects of Iron Supplements on the Pharmacokinetics of MT-6548
A Clinical Pharmacological Study to Evaluate the Effects of Iron Supplements on the Pharmacokinetics of MT-6548 in Healthy Male Volunteers
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 61 (actual)
- Sponsor
- Tanabe Pharma Corporation · Industry
- Sex
- Male
- Age
- 20 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The objectives of this study are to investigate the pharmacokinetics and safety of MT-6548 co-administered with iron supplements in healthy male volunteers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MT-6548 | Oral tablet |
| DRUG | Iron supplement A | Oral tablet |
| DRUG | Iron supplement B | Oral tablet |
| DRUG | Iron supplement C | Oral tablet |
| DRUG | Iron supplement D | Oral tablet |
Timeline
- Start date
- 2018-08-27
- Primary completion
- 2018-09-30
- Completion
- 2018-09-30
- First posted
- 2018-08-24
- Last updated
- 2026-04-06
- Results posted
- 2021-05-18
Locations
1 site across 1 country: Japan
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03645863. Inclusion in this directory is not an endorsement.